Anti Suicide Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Anti Suicide Drugs Market By Drug Class (Anti-depressants, Anti-anxiety drugs, Anti-psychotic drugs, NMDA Antagonists, Antibiotic analogues), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospitals, Clinics, Online pharmacies, Retail pharmacies) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Anti Suicide Drugs Market was valued at USD 4 billion in 2021 and expected to reach USD 5.3 billion by 2028 growing at a CAGR of 4% during the forecast period 2022 to 2028. Suicidal behaviour is defined as the preoccupation or act that is focussed on causing one’s own death voluntarily. To have suicidal intent is to have a suicide or deliberate self-killing as one’s purpose. Intent refers to the aim, purpose, or goal of the behaviour. The term indicates a conscious desire or wishes to leave or escape from life, and also suggests a resolve to act. This is contrasted with suicidal motivation, or the driving force behind ideation or intent, which need not be conscious. Development of effective anti-suicidal drugs can be a major breakthrough in reducing the death rate. Currently, non-profit organizations like Stop Suicide, Stop youth suicide and American foundation for suicide prevention are providing social and moral support to the people with suicidal thoughts and tendencies. Increased focus on R&D led to the launch of new range of drugs and a strong pipeline of drugs, which in turn propel the growth of the anti-suicide drugs market. For example, NeuroRX (Acquired by Allergan) completed the phase-II trial for cyclurad (combination of lurasidone and D-Cycloserine, conjugated with ketamine) to treat suicidal tendencies associated with bipolar disorder. Suicide rates are on the rise all across the world, which is one of the market’s primary drivers. Suicides accounted for about 1-1.5 percent of all deaths in 2017, according to the World Health Organization. Rising awareness about excellent mental health, shifting, greater focus on research and development leading to the launch of novel anti-suicidal medications are all factors contributing to the market’s growth.

Anti Suicide Drugs Market

MARKET SUMMARY
-
4% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–4%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Anti Suicide Drugs Market

  • The report on global Anti Suicide Drugs Market gives historical, current, and future market sizes (US$ Bn) on the basis of drug class, route of administration, distribution channel and geography.
  • Anti Suicide Drugs Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • AstraZeneca plc (UK)
  • Allergan plc (Republic of Ireland)
  • Eli Lilly and Company (UK)
  • H. Lundbeck A/S (Denmark)
  • GlaxoSmithKline plc (UK)
Dynamics

Anti Suicide Drugs Market

Some of the factors which are boosting the growth of Anti Suicide Drugs Market are growing population with depression, increasing different depression disorders such as clinical depressive syndrome, postpartum depression, psychotic depression and seasonal affective disorder etc., and growing suicidal incidences worldwide. As per statistics of WHO around 8,00,000 people are committing suicide every year globally especially among the age group of 15 – 29 years. However, a dearth of effective therapies, growing drug abuse and rise in usage of unapproved therapies are the few factors which are expected to restrain the growth of anti suicide drugs market.


North-America got significant share

Anti Suicide Drugs Market

Anti-Suicide Drugs Market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. North America and Europe are expected to gain attractive market share due to growing incidences of suicidal cases, rise in healthcare expenditure and launch a wide range of anti-suicidal drugs. As per, 2014 estimations of American Foundation for Suicide Prevention, the suicide rate in U.S was around 12.93 /1,000 people. Emerging countries in Asia Pacific region are expected to show the fastest growth during the forecast period due to growing awareness about the mental health, increasing visits of people to psychiatrists and psychologists, increase in the number of associations which are working on spreading the awareness, and rising suicide incidences. According to the data estimation of WHO in 2012, India, Russia, Guyana, Republic of Korea, Sri Lanka, Japan, and Kazakhstan are the nations with high suicidal rates.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Anti-Suicide Drugs Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Anti Suicide Drugs Market Introduction
    • Global Anti Suicide Drugs Market – Taxonomy
    • Global Anti Suicide Drugs Market –Definitions
      • Drug Class
      • Route of Administration
      • Distribution Channel
  1. Global Anti Suicide Drugs Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anti Suicide Drugs Market Dynamic Factors – Impact Analysis
    • Global Anti Suicide Drugs Market – Competition Landscape
    • Epidemiology
  2. Global Anti Suicide Drugs Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Anti Suicide Drugs Market, By Drug Class, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Anti-depressants
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-anxiety drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-psychotic drugs
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • NMDA Antagonists
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antibiotic analogues
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti Suicide Drugs Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2017 – 2024
    • Oral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti Suicide Drugs Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anti Suicide Drugs Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anti Suicide Drugs Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Region, 2018 – 2024
  2. North America Anti Suicide Drugs MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Anti Suicide Drugs Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2018 – 2024
    • North America Anti Suicide Drugs Market Dynamics – Trends
  3. Europe Anti Suicide Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anti Suicide Drugs Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel, and Country,2018 – 2024
    • Europe Anti Suicide Drugs Market Dynamics – Trends
  4. Asia-Pacific Anti Suicide Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Anti Suicide Drugs Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel, and Country,2018 – 2024
    • Asia-Pacific Anti Suicide Drugs Market Dynamics – Trends
  5. Latin America Anti Suicide Drugs Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Latin America Anti Suicide Drugs Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel, and Country,2018 – 2024
    • Latin America Anti Suicide Drugs Market Dynamics – Trends
  6. Middle East and Africa Anti Suicide Drugs Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Anti-depressants
      • Anti-anxiety drugs
      • Anti-psychotic drugs
      • NMDA Antagonists
      • Antibiotic analogues
    • Route of Administration Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Online pharmacies
      • Retail pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anti Suicide Drugs Market – Opportunity Analysis Index, By Drug Class, ByRoute of Administration, By Distribution Channel, and Country,2018 – 2024
    • MEA Anti Suicide Drugs Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • AstraZeneca plc (UK)
      • Allergan plc, Eli Lilly and Company (UK)
      • Lundbeck A/S (Denmark)
      • GlaxoSmithKline plc (UK)
      • Johnson & Johnson (U.S)
      • Merck & Co., Inc. (U.S)
      • Pfizer, Inc. (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • AstraZeneca plc (UK)
  • Allergan plc (Republic of Ireland)
  • Eli Lilly and Company (UK)
  • H. Lundbeck A/S (Denmark)
  • GlaxoSmithKline plc (UK)
  • Johnson & Johnson (U.S)
  • Merck & Co., Inc. (U.S)
  • Pfizer, Inc. (U.S)

Description

Anti Suicide Drugs Market was valued at USD 4 billion in 2021 and expected to reach USD 5.3 billion by 2028 growing at a CAGR of 4% during the forecast period 2022 to 2028. Suicidal behaviour is defined as the preoccupation or act that is focussed on causing one’s own death voluntarily. To have suicidal intent is to have a suicide or deliberate self-killing as one’s purpose. Intent refers to the aim, purpose, or goal of the behaviour. The term indicates a conscious desire or wishes to leave or escape from life, and also suggests a resolve to act. This is contrasted with suicidal motivation, or the driving force behind ideation or intent, which need not be conscious. Development of effective anti-suicidal drugs can be a major breakthrough in reducing the death rate. Currently, non-profit organizations like Stop Suicide, Stop youth suicide and American foundation for suicide prevention are providing social and moral support to the people with suicidal thoughts and tendencies. Increased focus on R&D led to the launch of new range of drugs and a strong pipeline of drugs, which in turn propel the growth of the anti-suicide drugs market. For example, NeuroRX (Acquired by Allergan) completed the phase-II trial for cyclurad (combination of lurasidone and D-Cycloserine, conjugated with ketamine) to treat suicidal tendencies associated with bipolar disorder. Suicide rates are on the rise all across the world, which is one of the market’s primary drivers. Suicides accounted for about 1-1.5 percent of all deaths in 2017, according to the World Health Organization. Rising awareness about excellent mental health, shifting, greater focus on research and development leading to the launch of novel anti-suicidal medications are all factors contributing to the market’s growth.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX